The report covers forecast and analysis for the peptide therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the peptide therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the peptide therapeutics market on a global level.
In order to give the users of this report a comprehensive view of the peptide therapeutics market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type, and regional expansion of major participants involved in the market.
The study provides a decisive view on the peptide therapeutics market by segmenting it on the route of administration, type, type of manufacturers, type of molecule, technology, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further categorization into major countries including the U.S., the UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for peptide therapeutics market based on all segments in all the regions and countries.
The key players in the global peptide therapeutics market are Amgen Inc., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd., Lonza Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Sanofi, AstraZeneca PLC, and Novartis AG.
This report segments the global peptide therapeutics market as follows:
Global Peptide Therapeutics Market: Route of Administration Segment Analysis
- Parenteral
- Oral
- Others
Global Peptide Therapeutics Market: Type Segment Analysis
- Innovative
- Generic
Global Peptide Therapeutics Market: Type of Manufacturers Segment Analysis
- In-house
- Outsourced
Global Peptide Therapeutics Market: Type of Molecule Segment Analysis
- Vasopressin
- Somatostatin
- Calcitonin
- Immunopeptide
- Natriuretic
- Others
Global Peptide Therapeutics Market: Technology Segment Analysis
- Solid Phase
- Liquid Phase
- Hybrid Phase
Global Peptide Therapeutics Market: Application Segment Analysis
- Cancer
- Cardiovascular Disease
- Metabolic Disease
- Respiratory Disease
- Infectious Disease
- Others
Global Peptide Therapeutics Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
